Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
27.05.2025 16:19:11
|
Eli Lilly To Acquire SiteOne Therapeutics For $1 Bln In Cash
(RTTNews) - Eli Lilly and Company (LLY), Tuesday announced an agreement regarding the acquisition of SiteOne Therapeutics, Inc., a private biotechnology company, for upto $1 billion in cash, including an upfront payment and subsequent milestone payments.
The acquisition includes STC-004, a Phase 2 ready Nav1.8 inhibitor being studied for the treatment of pain.
Upon the completion of the deal, the company expects to continue the development of STC-004 along with the SiteOne team, paving way for advancement of new non-opioid medicines for pain management.
Currently, LLY is trading at $719.54, up 0.82 percent on the New York Stock Exchange.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 700,00 | -0,43% |
|